Product Launch Announcement: Lenvaheal 4 (Lenvatinib 4mg) Capsule
We are proud to introduce Lenvaheal 4 capsules is a targeted oral anticancer therapy containing Lenvatinib 4mg, designed to inhibit tumor growth and angiogenesis. It is widely used in the management of advanced and progressive cancers, offering a clinically proven option with precision-driven action.
🔍 Product Overview
Generic Name: Lenvatinib
Strength: 4mg
Formulation: Capsules
Primary Indications:
Lenvaheal 4 -Lenvatinib 4mg capsule is indicated for the treatment of:
- Differentiated Thyroid Cancer (DTC) refractory to radioactive iodine
- Advanced Renal Cell Carcinoma (RCC) (often in combination therapy)
- Unresectable Hepatocellular Carcinoma (HCC)
- Endometrial carcinoma (in combination with other agents, as prescribed)
Mechanism of Action:
Lenvatinib is a multi-kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR 1–3) and other pro-angiogenic and oncogenic pathway receptors. By blocking these pathways, Lenvaheal 4 reduces tumor blood supply, slows cancer cell proliferation, and inhibits disease progression.
💡 Key Benefits
- Oral, targeted therapy with systemic efficacy
- Inhibits tumor angiogenesis and growth pathways
- Demonstrated clinical benefit across multiple solid tumors
- Convenient capsule formulation for patient compliance
- Suitable for long-term cancer management under supervision
🎯 Target Audience
- Oncologists and cancer specialists
- Hospitals and oncology treatment centers
- Specialty pharmacies and distributors
- Patients requiring targeted therapy for advanced cancers
🏥 Commitment to Clinical Excellence
Lenvaheal 4 is manufactured under stringent quality standards, ensuring safety, consistency, and therapeutic reliability. Every batch is produced in compliance with international regulatory guidelines, reinforcing trust among healthcare professionals and patients alike.
📦 Availability
Lenvaheal 4 -Lenvatinib 4mg Capsules are available through authorized pharmaceutical distributors. For ordering, partnerships, or regulatory information, please contact the marketing authorization holder.
Lenvaheal 4 – Because Every Target Matters
